Newronika received a CE Mark for the latest release of αDBS, its adaptive deep brain stimulation system. Unlike conventional DBS, which delivers constant stimulation, an adaptive system senses brain signals continuously and adjusts stimulation to match the patient's changing state. The Milan company describes this as the first approval for an adaptive DBS system that also transmits neural data into a connected cloud platform, building a longitudinal repository that grows with each patient treated. The system remains investigational in the US.